论文部分内容阅读
医药零售连锁是现代服务业主要经营业态之一,从2011年5月商务部发布的《全国药品流通行业发展规划纲要(2011-2015年)》提出:“十二五”期间药品零售连锁企业年销售额占药品零售企业销售总额的比例占到60%以上发展的具体目标以来,不少大型的连锁药店企业都欲图实现新的兼并计划,而连锁药店对个体药店实现并购,通常来说会面临一些风险问题,主要是在前期的环境、法律、政策、财务风险等以及在后期的管理运营与资金的投放使用等风险。针对于这样的情况,对于连锁药店实现个体药店并购相应风险的控制,无疑也变得十分重要。
The retail chain of medicine is one of the major business modes of modern service industry. From “2011-2015 Outline of Development Plan of National Drug Circulation Industry” promulgated by the Ministry of Commerce in May 2011: “The retail chain of medicines during the” 12th Five-Year Plan " Since the annual sales of enterprises account for more than 60% of the total sales of pharmaceutical retail enterprises, many large-scale pharmaceutical chain enterprises are trying to achieve a new merger plan. However, That will face some risk issues, mainly in the early stage of the environment, laws, policies, financial risks, as well as in the latter part of the management and operation of the use of funds and other risks. In response to such a situation, the chain pharmacy to achieve the appropriate risk control of individual pharmacies merger, no doubt has become very important.